Send us a text

What if brain health were as actionable as heart health—measured early, managed proactively, and supported by tools you can use at home? In this conversation from the Ideagen Global Leadership Summit, we bring together a startup CEO, a medtech innovator, and an age-tech investor to map a path from stigma and late-stage crisis to early detection, prevention, and real treatment options.

The discussion begins by distinguishing Alzheimer’s disease from the broader dementia syndrome, then explores how screening for mild cognitive impairment in primary care could transform lives, finances, and care plans—long before crisis hits.

We unpack the evolving therapy landscape with clarity and realism. Monoclonal antibodies targeting amyloid offer promise but face access and safety challenges. Meanwhile, noninvasive neurostimulation—precisely tuned light and sound to activate neural pathways—is showing potential as a safe, accessible complement to drug-based therapies. Combined with lifestyle interventions like sleep, exercise, and hearing care, the future looks more like coordinated, combination therapy than a single silver bullet.

But breakthroughs need systems that work. The panel gets practical about reimbursement gaps, CMS pathways, and embedding AI-driven cognitive assessments into everyday primary care. Their message to leaders: financial courage, policy alignment, and prevention-first frameworks are essential. Their message to all of us: everyone experiences cognitive change—the choice is whether to prepare.

Get your baseline, talk to your clinician, and share this conversation with someone you love. If this resonates, follow the show, leave a review, and tell us: what’s the next step you’ll take for your brain health?